These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

345 related articles for article (PubMed ID: 11804596)

  • 1. DNA damage-dependent acetylation of p73 dictates the selective activation of apoptotic target genes.
    Costanzo A; Merlo P; Pediconi N; Fulco M; Sartorelli V; Cole PA; Fontemaggi G; Fanciulli M; Schiltz L; Blandino G; Balsano C; Levrero M
    Mol Cell; 2002 Jan; 9(1):175-86. PubMed ID: 11804596
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The transcriptional coactivator Yes-associated protein drives p73 gene-target specificity in response to DNA Damage.
    Strano S; Monti O; Pediconi N; Baccarini A; Fontemaggi G; Lapi E; Mantovani F; Damalas A; Citro G; Sacchi A; Del Sal G; Levrero M; Blandino G
    Mol Cell; 2005 May; 18(4):447-59. PubMed ID: 15893728
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functional inactivation of p73, a homolog of p53 tumor suppressor protein, by human papillomavirus E6 proteins.
    Park JS; Kim EJ; Lee JY; Sin HS; Namkoong SE; Um SJ
    Int J Cancer; 2001 Mar; 91(6):822-7. PubMed ID: 11275986
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of the p53 homolog p73 by adenoviral oncogene E1A.
    Das S; El-Deiry WS; Somasundaram K
    J Biol Chem; 2003 May; 278(20):18313-20. PubMed ID: 12639967
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The potential tumor suppressor p73 differentially regulates cellular p53 target genes.
    Zhu J; Jiang J; Zhou W; Chen X
    Cancer Res; 1998 Nov; 58(22):5061-5. PubMed ID: 9823311
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment with arsenic trioxide (ATO) and MEK1 inhibitor activates the p73-p53AIP1 apoptotic pathway in leukemia cells.
    Lunghi P; Costanzo A; Levrero M; Bonati A
    Blood; 2004 Jul; 104(2):519-25. PubMed ID: 15031205
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Distinct regulation of p53 and p73 activity by adenovirus E1A, E1B, and E4orf6 proteins.
    Steegenga WT; Shvarts A; Riteco N; Bos JL; Jochemsen AG
    Mol Cell Biol; 1999 May; 19(5):3885-94. PubMed ID: 10207112
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DN-p73 is activated after DNA damage in a p53-dependent manner to regulate p53-induced cell cycle arrest.
    Vossio S; Palescandolo E; Pediconi N; Moretti F; Balsano C; Levrero M; Costanzo A
    Oncogene; 2002 May; 21(23):3796-803. PubMed ID: 12032848
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adenovirus-mediated transfer of p53-related genes induces apoptosis of human cancer cells.
    Ishida S; Yamashita T; Nakaya U; Tokino T
    Jpn J Cancer Res; 2000 Feb; 91(2):174-80. PubMed ID: 10761704
    [TBL] [Abstract][Full Text] [Related]  

  • 10. p73 is transcriptionally regulated by DNA damage, p53, and p73.
    Chen X; Zheng Y; Zhu J; Jiang J; Wang J
    Oncogene; 2001 Feb; 20(6):769-74. PubMed ID: 11314010
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interferon regulatory factor 1 binding to p300 stimulates DNA-dependent acetylation of p53.
    Dornan D; Eckert M; Wallace M; Shimizu H; Ramsay E; Hupp TR; Ball KL
    Mol Cell Biol; 2004 Nov; 24(22):10083-98. PubMed ID: 15509808
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pin1 links the activities of c-Abl and p300 in regulating p73 function.
    Mantovani F; Piazza S; Gostissa M; Strano S; Zacchi P; Mantovani R; Blandino G; Del Sal G
    Mol Cell; 2004 Jun; 14(5):625-36. PubMed ID: 15175157
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Wild-type p53 and p73 negatively regulate expression of proliferation related genes.
    Scian MJ; Carchman EH; Mohanraj L; Stagliano KE; Anderson MA; Deb D; Crane BM; Kiyono T; Windle B; Deb SP; Deb S
    Oncogene; 2008 Apr; 27(18):2583-93. PubMed ID: 17982488
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative analysis of p73 and p53 regulation and effector functions.
    Fang L; Lee SW; Aaronson SA
    J Cell Biol; 1999 Nov; 147(4):823-30. PubMed ID: 10562283
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transcriptional regulation by p53 and p73.
    Lokshin M; Tanaka T; Prives C
    Cold Spring Harb Symp Quant Biol; 2005; 70():121-8. PubMed ID: 16869745
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumour-suppressor genes. Killer in search of a motive?
    Clurman B; Groudine M
    Nature; 1997 Sep; 389(6647):122-3. PubMed ID: 9296483
    [No Abstract]   [Full Text] [Related]  

  • 17. p21/CDKN1A mediates negative regulation of transcription by p53.
    Löhr K; Möritz C; Contente A; Dobbelstein M
    J Biol Chem; 2003 Aug; 278(35):32507-16. PubMed ID: 12748190
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Myc suppression of the p21(Cip1) Cdk inhibitor influences the outcome of the p53 response to DNA damage.
    Seoane J; Le HV; Massagué J
    Nature; 2002 Oct; 419(6908):729-34. PubMed ID: 12384701
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Yap1 phosphorylation by c-Abl is a critical step in selective activation of proapoptotic genes in response to DNA damage.
    Levy D; Adamovich Y; Reuven N; Shaul Y
    Mol Cell; 2008 Feb; 29(3):350-61. PubMed ID: 18280240
    [TBL] [Abstract][Full Text] [Related]  

  • 20. c-Abl tyrosine kinase selectively regulates p73 nuclear matrix association.
    Ben-Yehoyada M; Ben-Dor I; Shaul Y
    J Biol Chem; 2003 Sep; 278(36):34475-82. PubMed ID: 12824179
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.